Joseph Benesch

CIK: 0001887515

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

DERM

Journey Medical Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

DERM
Journey Medical Corp
Apr 22, 2026
Award(A)
Direct
28.9K shares-
DERM
Journey Medical Corp
Jun 17, 2025
Award(A)
Direct
28.9K shares-
DERM
Journey Medical Corp
May 2, 2025
Sale(S)
Direct
2.4K shares at avg. $6.84$16K
DERM
Journey Medical Corp
Feb 21, 2025
Sale(S)
Direct
1.4K shares at avg. $5.19$7K
DERM
Journey Medical Corp
May 1, 2024
Award(A)
Direct
80K shares-
DERM
Journey Medical Corp
Jan 3, 2024
Award(A)
Direct
80K shares-

		Type	Shares	Price		Ownership
Apr 22, 2026	DERM Journey Medical Corp	Award(A)	28,907	-	$0	Direct
Jun 17, 2025	DERM Journey Medical Corp	Award(A)	28,907	-	-	Direct
May 2, 2025	DERM Journey Medical Corp	Sale(S)	2,409	$6.84	$16,478	Direct
Feb 21, 2025	DERM Journey Medical Corp	Sale(S)	1,365	$5.19	$7,084	Direct
May 1, 2024	DERM Journey Medical Corp	Award(A)	80,000	-	-	Direct
Jan 3, 2024	DERM Journey Medical Corp	Award(A)	80,000	-	-	Direct

1-6 of 6 transactions

About Benesch Joseph

Benesch Joseph (SEC CIK 0001887515) files insider reports with the SEC as CFO of Journey Medical Corp (DERM).

Signal8 holds 5 ownership filings by Benesch Joseph, all Form 4s, filed between Feb 24, 2025 and Apr 24, 2026. Those filings report 6 transactions, from Jan 3, 2024 to Apr 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Benesch Joseph's filings is in SCOTTSDALE, AZ.

Recent filings by Benesch Joseph

Apr 22, 2026: Grant or award of DERM shares (Form 4, code A).
Jun 17, 2025: Grant or award of DERM shares (Form 4, code A).
May 2, 2025: Open-market sale of DERM shares (Form 4, code S).
Feb 21, 2025: Open-market sale of DERM shares (Form 4, code S).
May 1, 2024: Grant or award of DERM shares (Form 4, code A).

Other insiders filing for Journey Medical Corp (DERM)

Toledano Miranda Jayne, Director
Smith Justin Adam, Director
Herskowitz Neil, Director
Pearce Michael Cooper, Director
ROSENWALD LINDSAY A MD, Director
Alloush Ramsey, Chief Operating Officer

How to read Form 4 transaction codes